title: New medicines - urgent need to assess outcomes in special groups.
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Martin
authors.forename: Michael D
authors.initials: MD
authors.lastname: Coory
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D006801:Humans; D020521:Stroke / Q000517:prevention & control*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran